OneBlood’s mission is to enhance the health and well-being of others through its work with blood and stem cell products and by facilitating scientific research.
OneBlood is an industry-leading blood center that is known for its innovative and progressive approaches. Drawing on more than 70 years of blood banking experience, OneBlood cultivates a partnership between the blood donor community and the medical research space. Partnering with OneBlood provides HemaCare with an East Coast presence and access to a diverse pool of well-characterized qualified donors demonstrating HemaCare’s commitment of providing a wide array of high-quality blood products to the high growth biotechnology, pharmaceutical, and academic global research markets.
Charles River is a leading early-stage contract research organization who provides essential products and services to pharmaceutical and biotechnology companies, government agencies, and leading academic institutions to help accelerate their research and drug development efforts. HemaCare and Charles River have formed a partnership to advance human immune system research by developing a more efficient and reliable method of working with humanized mice. Under this partnership, vials of pre-selected peripheral blood mononuclear cells (PBMCs) from HemaCare will be integrated into Charles River’s NCG/PBMC Select Humanization Kit, allowing the researcher to efficiently develop the humanized mouse model.
Success in the regenerative medicine, biobanking, and drug discovery industries depends on the shelf life and viability of cells, tissues, and organs designated for research or clinical applications. Hand in hand with many of these applications is the need for high quality biologically functional cells. BioLife Solutions and HemaCare have partnered together to help you be successful with controlled, consistently functional cells and best-in-class, cGMP-grade biopreservation media products that significantly extend stability and improve post-biopreservation viability and function of your biologic source material, intermediates, and final products.
HemaCare has partnered with Tissue Solutions, a leading global provider of human biological materials, to supply clients with disease-state samples in fresh, frozen, and FFPE formats. With one of the world’s largest networks of ethically approved human biospecimens, HemaCare customers now have access to high-quality, well-characterized materials from a wide range of disease types that can be sourced with short turnaround times to advance your research and development project on your timelines.
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. The company’s integrated tools support research at every level, from basic research to translational research to clinical application. Their technologies cover techniques of sample preparation, cell isolation, flow sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. The company’s more than 25 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. Trusted around the world, the Miltenyi Biotec brand continues to set new standards in the industry.
The Cryoport Solution replaces dry ice, virtually eliminating the risk of cell degradation during frozen transportation. Cryoport uses custom-built liquid nitrogen dry vapor shippers to maintain stable temperatures. Cryoport is the expert in deep-frozen shipping for biological materials with the most advanced Logistics Management Platform in the industry.